StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) stock

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$690.24−10.41 (-1.49%)

Close on Nov 17, 2026Market cap $54.38BP/E 48.5Yield –

IDEXX Laboratories gross margin

Gross margin is gross profit as a percentage of revenue.

IDEXX Laboratories's gross margin for the twelve months ending Jun 30, 2026 was 62.4%. For fiscal 2025 it was 61.8%, against 61.0% the year before. The highest annual figure on record is 61.8% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202561.8%+0.8
FY2024Dec 31, 202461.0%+1.2
FY2023Dec 31, 202359.8%+0.3
FY2022Dec 31, 202259.5%+0.8
FY2021Dec 31, 202158.8%+0.7
FY2020Dec 31, 202058.0%+1.3
FY2019Dec 31, 201956.7%+0.6
FY2018Dec 31, 201856.1%+0.4
FY2017Dec 31, 201755.7%+0.8
FY2016Dec 31, 201654.9%−0.6
FY2015Dec 31, 201555.6%+0.6
FY2014Dec 31, 201454.9%+0.0
FY2013Dec 31, 201354.9%+0.9
FY2012Dec 31, 201254.1%+1.0
FY2011Dec 31, 201153.0%+0.6
FY2010Dec 31, 201052.4%+1.4
FY2009Dec 31, 200951.0%−0.7
FY2008Dec 31, 200851.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202664.0%+1.4
Q1 FY2026Mar 31, 202663.4%+0.9
Q4 FY2025Dec 31, 202560.3%+0.5
Q3 FY2025Sep 30, 202561.8%+0.7
Q2 FY2025Jun 30, 202562.6%+0.9
Q1 FY2025Mar 31, 202562.4%+0.9
Q4 FY2024Dec 31, 202459.8%+1.4
Q3 FY2024Sep 30, 202461.1%+1.2
Q2 FY2024Jun 30, 202461.7%+1.0
Q1 FY2024Mar 31, 202461.5%+1.2
Q4 FY2023Dec 31, 202358.4%−0.2
Q3 FY2023Sep 30, 202359.9%−0.3
Q2 FY2023Jun 30, 202360.7%+1.0
Q1 FY2023Mar 31, 202360.3%+0.7
Q4 FY2022Dec 31, 202258.5%+1.6
Q3 FY2022Sep 30, 202260.2%+1.8
Q2 FY2022Jun 30, 202259.7%+0.5
Q1 FY2022Mar 31, 202259.6%−0.9
Q4 FY2021Dec 31, 202157.0%+0.2
Q3 FY2021Sep 30, 202158.4%−0.2
Q2 FY2021Jun 30, 202159.2%−0.3
Q1 FY2021Mar 31, 202160.5%+3.1
Q4 FY2020Dec 31, 202056.8%+2.1
Q3 FY2020Sep 30, 202058.5%+1.6
Q2 FY2020Jun 30, 202059.5%+1.8
Q1 FY2020Mar 31, 202057.4%−0.2
Q4 FY2019Dec 31, 201954.7%+0.0
Q3 FY2019Sep 30, 201957.0%+1.0
Q2 FY2019Jun 30, 201957.7%+0.5
Q1 FY2019Mar 31, 201957.6%+1.2
Q4 FY2018Dec 31, 201854.7%+0.8
Q3 FY2018Sep 30, 201856.0%+0.3
Q2 FY2018Jun 30, 201857.2%−0.3
Q1 FY2018Mar 31, 201856.4%+0.5
Q4 FY2017Dec 31, 201753.8%−0.5
Q3 FY2017Sep 30, 201755.7%+0.7
Q2 FY2017Jun 30, 201757.5%–
Q1 FY2017Mar 31, 201755.9%–
Q4 FY2016Dec 31, 201654.3%–
Q3 FY2016Sep 30, 201655.0%–

More IDEXX Laboratories figures

See a number that looks wrong?